Cargando…
Integrating molecular biomarkers in breast cancer rehabilitation. What is the current evidence? A systematic review of randomized controlled trials
Background: Quality of life issues is a crucial burden in breast cancer (BC) survivors with relevant implications in terms of survivorship and health-care costs. The increasing long-term survival of these patients provides new challenges, with translational research now focusing on innovative and ta...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493088/ https://www.ncbi.nlm.nih.gov/pubmed/36158576 http://dx.doi.org/10.3389/fmolb.2022.930361 |
_version_ | 1784793621642346496 |
---|---|
author | Invernizzi, Marco Lippi, Lorenzo Folli, Arianna Turco, Alessio Zattoni, Lorenzo Maconi, Antonio de Sire, Alessandro Fusco, Nicola |
author_facet | Invernizzi, Marco Lippi, Lorenzo Folli, Arianna Turco, Alessio Zattoni, Lorenzo Maconi, Antonio de Sire, Alessandro Fusco, Nicola |
author_sort | Invernizzi, Marco |
collection | PubMed |
description | Background: Quality of life issues is a crucial burden in breast cancer (BC) survivors with relevant implications in terms of survivorship and health-care costs. The increasing long-term survival of these patients provides new challenges, with translational research now focusing on innovative and tailored approaches to improve their complex management. In this scenario, several emerging biomarkers have the potential to improve the clinical rehabilitative management of patients with BC. However, to date, guidelines supporting biomarker implementation in this area are still lacking. Therefore, the aim of this systematic review was to summarize the currently available biomarkers that might be potentially integrated into rehabilitation practice to promote a precision medicine approach to BC survivorship issues. Methods: On 9th March 2022, PubMed, Scopus, Web of Science, Cochrane, and PEDro were systematically searched for randomized controlled trials (RCTs) assessing rehabilitation interventions in BC patients. Molecular biomarker modifications induced by physical exercise have been assessed through the review of the study protocols and published results. The Jadad scale was used to assess the quality of the studies included. Results: Out of 2,224 records, 22 studies were included in the present systematic review. Exercise therapy showed significant results in 15 RCTs, in terms of metabolic biomarkers, including glycemic and insulin profile, and lipid profile (p ≤ 0.05). Similarly, 12 studies underlined significant effects in inflammation and immune response biomarkers, including TNF-α, IL-6, IL-10, C-reactive protein, leptin, and adiponectin (p ≤ 0.05). On the other hand, cardiac biomarkers were assessed in three studies without reporting significant differences after exercise therapy (p = NS). The quality assessment identified 19 RCTs as high-quality studies and three RCTs of low quality. Conclusion: Our findings reveal significant biochemical perturbations in key molecules induced by physical exercise in patients with BC, suggesting room for the implementation of actionable biomarkers. Future research might clarify the role of biomarkers on treatment effectiveness monitoring, to optimize rehabilitative strategies tailored to patient’s needs. |
format | Online Article Text |
id | pubmed-9493088 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94930882022-09-23 Integrating molecular biomarkers in breast cancer rehabilitation. What is the current evidence? A systematic review of randomized controlled trials Invernizzi, Marco Lippi, Lorenzo Folli, Arianna Turco, Alessio Zattoni, Lorenzo Maconi, Antonio de Sire, Alessandro Fusco, Nicola Front Mol Biosci Molecular Biosciences Background: Quality of life issues is a crucial burden in breast cancer (BC) survivors with relevant implications in terms of survivorship and health-care costs. The increasing long-term survival of these patients provides new challenges, with translational research now focusing on innovative and tailored approaches to improve their complex management. In this scenario, several emerging biomarkers have the potential to improve the clinical rehabilitative management of patients with BC. However, to date, guidelines supporting biomarker implementation in this area are still lacking. Therefore, the aim of this systematic review was to summarize the currently available biomarkers that might be potentially integrated into rehabilitation practice to promote a precision medicine approach to BC survivorship issues. Methods: On 9th March 2022, PubMed, Scopus, Web of Science, Cochrane, and PEDro were systematically searched for randomized controlled trials (RCTs) assessing rehabilitation interventions in BC patients. Molecular biomarker modifications induced by physical exercise have been assessed through the review of the study protocols and published results. The Jadad scale was used to assess the quality of the studies included. Results: Out of 2,224 records, 22 studies were included in the present systematic review. Exercise therapy showed significant results in 15 RCTs, in terms of metabolic biomarkers, including glycemic and insulin profile, and lipid profile (p ≤ 0.05). Similarly, 12 studies underlined significant effects in inflammation and immune response biomarkers, including TNF-α, IL-6, IL-10, C-reactive protein, leptin, and adiponectin (p ≤ 0.05). On the other hand, cardiac biomarkers were assessed in three studies without reporting significant differences after exercise therapy (p = NS). The quality assessment identified 19 RCTs as high-quality studies and three RCTs of low quality. Conclusion: Our findings reveal significant biochemical perturbations in key molecules induced by physical exercise in patients with BC, suggesting room for the implementation of actionable biomarkers. Future research might clarify the role of biomarkers on treatment effectiveness monitoring, to optimize rehabilitative strategies tailored to patient’s needs. Frontiers Media S.A. 2022-09-08 /pmc/articles/PMC9493088/ /pubmed/36158576 http://dx.doi.org/10.3389/fmolb.2022.930361 Text en Copyright © 2022 Invernizzi, Lippi, Folli, Turco, Zattoni, Maconi, de Sire and Fusco. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Biosciences Invernizzi, Marco Lippi, Lorenzo Folli, Arianna Turco, Alessio Zattoni, Lorenzo Maconi, Antonio de Sire, Alessandro Fusco, Nicola Integrating molecular biomarkers in breast cancer rehabilitation. What is the current evidence? A systematic review of randomized controlled trials |
title | Integrating molecular biomarkers in breast cancer rehabilitation. What is the current evidence? A systematic review of randomized controlled trials |
title_full | Integrating molecular biomarkers in breast cancer rehabilitation. What is the current evidence? A systematic review of randomized controlled trials |
title_fullStr | Integrating molecular biomarkers in breast cancer rehabilitation. What is the current evidence? A systematic review of randomized controlled trials |
title_full_unstemmed | Integrating molecular biomarkers in breast cancer rehabilitation. What is the current evidence? A systematic review of randomized controlled trials |
title_short | Integrating molecular biomarkers in breast cancer rehabilitation. What is the current evidence? A systematic review of randomized controlled trials |
title_sort | integrating molecular biomarkers in breast cancer rehabilitation. what is the current evidence? a systematic review of randomized controlled trials |
topic | Molecular Biosciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493088/ https://www.ncbi.nlm.nih.gov/pubmed/36158576 http://dx.doi.org/10.3389/fmolb.2022.930361 |
work_keys_str_mv | AT invernizzimarco integratingmolecularbiomarkersinbreastcancerrehabilitationwhatisthecurrentevidenceasystematicreviewofrandomizedcontrolledtrials AT lippilorenzo integratingmolecularbiomarkersinbreastcancerrehabilitationwhatisthecurrentevidenceasystematicreviewofrandomizedcontrolledtrials AT folliarianna integratingmolecularbiomarkersinbreastcancerrehabilitationwhatisthecurrentevidenceasystematicreviewofrandomizedcontrolledtrials AT turcoalessio integratingmolecularbiomarkersinbreastcancerrehabilitationwhatisthecurrentevidenceasystematicreviewofrandomizedcontrolledtrials AT zattonilorenzo integratingmolecularbiomarkersinbreastcancerrehabilitationwhatisthecurrentevidenceasystematicreviewofrandomizedcontrolledtrials AT maconiantonio integratingmolecularbiomarkersinbreastcancerrehabilitationwhatisthecurrentevidenceasystematicreviewofrandomizedcontrolledtrials AT desirealessandro integratingmolecularbiomarkersinbreastcancerrehabilitationwhatisthecurrentevidenceasystematicreviewofrandomizedcontrolledtrials AT fusconicola integratingmolecularbiomarkersinbreastcancerrehabilitationwhatisthecurrentevidenceasystematicreviewofrandomizedcontrolledtrials |